These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Natural mutation of GABAA receptor alpha 6 subunit alters benzodiazepine affinity but not allosteric GABA effects.
    Author: Korpi ER, Seeburg PH.
    Journal: Eur J Pharmacol; 1993 Sep 15; 247(1):23-7. PubMed ID: 8258357.
    Abstract:
    The binding of the imidazobenzodiazepine, [3H]Ro 15-4513, to cerebellar granule cell-specific GABAA/benzodiazepine receptors is typically insensitive to benzodiazepine receptor agonists such as diazepam. A mutation in the alpha 6 subunit, causing replacement of the arginine at the 100 position by glutamine (Q100), has recently been found in an alcohol- and benzodiazepine-sensitive rat line. The mutant alpha 6(Q100)beta 2 gamma 2 recombinant receptors are sensitive to diazepam. The binding of [3H]Ro 15-4513 to cerebellar diazepam-insensitive receptors is enhanced by GABA, whereas binding to diazepam-sensitive receptors is inhibited. Recombinant receptors consisting of beta 2 and gamma 2 subunits together with the wildtype alpha 6 or mutant alpha 6(Q100) subunit showed positive modulation of [3H]Ro 15-4513 binding by GABA, whereas alpha 1 beta 2 gamma 2 receptors showed negative modulation. The picrotoxin-sensitive binding of a convulsant, t-butylbicyclophosphoro[35S]thionate ([35S]TBPS), was inhibited in the alpha 6 beta 2 gamma 2 and alpha 6(Q100) beta 2 gamma 2 receptors by GABA at concentrations less than one-tenth of those required in the alpha 1 beta 2 gamma 2 receptors. GABA effects on [35S]TBPS binding were only slightly affected by diazepam in the alpha 6(Q100) beta 2 gamma 2 receptors, while profound effects were seen in the alpha 1 beta 2 gamma 2 receptors in the presence of diazepam. The results with the mutant receptor suggest that the alpha 1 and alpha 6 subunits are responsible for differential allosteric actions by GABA on other binding sites, independently of the structures defining the benzodiazepine binding pharmacology.
    [Abstract] [Full Text] [Related] [New Search]